Molecular characterisation of soft tissue tumours: A gene expression study

Lancet

Volumn 359, Issue 9314, 2002, Pages 1301-1307

  Nielsen, Torsten O ^a   West, Rob B ^c   Linn, Sabine C ^c   Alter, Orly ^c   Knowling, Margaret A ^b   O'Connell, John X ^a,b   Zhu, Shirley ^c   Fero, Mike ^c   Sherlock, Gavin ^c   Pollack, Jonathan R ^c   Brown, Patrick O ^c   Botstein, David ^c   Van De Rijn, Matt ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOPROTEIN; MYOSIN; OSTEOGENIC PROTEIN 1; PROTEIN; PROTEIN ABCC4; PROTEIN ACTA2; PROTEIN ACTG2; PROTEIN CEP2; PROTEIN ENC1; PROTEIN GUCY1A3; PROTEIN IRX5; PROTEIN LMOD1; PROTEIN MYH11; PROTEIN MYLK; PROTEIN MYPT2; PROTEIN MYRL2; PROTEIN SLAP; PROTEIN SPRY1; PROTEIN SSX3; PROTEIN SSX4; RETINOIC ACID BINDING PROTEIN; RETINOIC ACID RECEPTOR GAMMA; SARCOGLYCAN; STEM CELL FACTOR; SYNAPTOJANIN; TRANSCRIPTION FACTOR MSX2; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOFIBROMA; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE MARKER; DNA MICROARRAY; FIBROBLAST; GASTROINTESTINAL TUMOR; GENE EXPRESSION; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; MESENCHYME; MUSCLE CELL; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE TUMOR; SYNOVIAL SARCOMA; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS;

EID: 0037070754     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08270-3     Document Type: Article

References (36)

1. The chipping forecast
2. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
3. Molecular portraits of human breast tumours
4. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
5. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
6. Molecular classification of cutaneous malignant melanoma by gene expression profiling
7. Delineation of prognostic biomarkers in prostate cancer
8. Cluster analysis and display of genome-wide expression patterns
9. Singular value decomposition for genome-wide expression data processing and modeling
10. Detection and multichannel SVD-based filtering of trigeminal somatosensory evoked potentials
11. Analysis of 12-lead T-wave morphology for risk stratification after myocardial infarction
12. Delay and dispersion effects in dynamic susceptibility contrast MRI: Simulations using singular value decomposition
13. Significance analysis of microarrays applied to the ionizing radiation response
14. Molecular mechanisms underlying human synovial sarcoma development
15. Cloning of human ENC-1 and evaluation of its expression and regulation in nervous system tumors
16. Xiro, a Xenopus homolog of the Drosophila Iroquois complex genes, controls development at the neural plate
17. Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis
18. Retinoic acid-dependent transforming growth factor-b2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-alpha signaling pathway
19. On receptor inhibitors and chemotherapy
20. Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer
21. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
22. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT)
23. Phosphatidylinositol 39-kinase associates with p145c-kit as part of a cell type characteristic multimeric signalling complex
24. Increased Kit/SCF receptor induced mitogenicity but abolished cell motility after inhibition of protein kinase C
25. Sarcomas of the soft tissue and bone
26. An inventory of the human ABC proteins
27. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: Differences in clinical outcome and expression of multidrug resistance proteins
28. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract
29. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
30. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
31. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: Prognostic relevance of subclassification